The EAHP Board, elected for three-year terms, oversees the association’s activities. Comprising directors responsible for core functions, it meets regularly to implement strategic goals. Supported by EAHP staff, the Board controls finances, coordinates congress organization, and ensures compliance with statutes and codes of conduct.
COVID-19: Practical examples of Clinical and Hospital Pharmacy Services for COVID-19 patients
In May 2020 the EAHP and ESCP collected inspiring examples of clinical and hospital pharmacy services for COVID19-patients. Selected examples will present how they delivered COVID19 pharmaceutical care in their hospitals. Furthermore, a COVID19 pharmacotherapy update will be provided.
Agenda
19.00-19.05 Opening
ESCP – Prof. Dr. Bart van den Bemt, PharmD/PhD, President of the ESCP
19.05-19.30 Clinical update on COVID19: actual treatment guidelines
Prof. Dr. Isabel Spriet, KU Leuven and clinical pharmacist at UZ Leuven, Belgium
19.30-19.50 Results of the qualitative study of the ESCP on the impact of the COVID19 pandemic on clinical pharmacy practice
Dr Vibhu Paudyal BPharm, MSc, PhD, SRPharmS (Senior Lecturer in Clinical, Pharmacy, School of Pharmacy, College of Medical and Dental Sciences, Sir Robert Aitken Institute for Medical Research, University of Birmingham)
19.50-20.10 Inspiring example of clinical/hospital pharmacy services for COVID19 patients: example 1 | Belgium: Hospital AZ Sint-Lucas in Gent
Nilgün Kizilmese (PharmD) & Kenny Noerens (PharmD)
20.10-20.30 Inspiring example of clinical/hospital pharmacy services for COVID19 patients: example 2 | Italy: Fatebenefratelli-Sacco Hospital in Milan
Dr Edoardo Calzavara (Pharmacist following the Specialization in Hospital Pharmacy) &
Dr Lorenzo Gambitta (Pharmacist following the Specialization in Hospital Pharmacy)
20.30-20.50 Inspiring example of clinical/hospital pharmacy services for COVID19 patients: example 3 | the Netherlands: COVID Medication Coordination Centre (LCG)
Rob Moss (Stakeholder manager for the Dutch National COVID Medication Coordination Centre)
20.50-21:00 Wrap up and closing
Learning objectives
After the webinar, participants should be able to:
- Overview the possible (preventive) pharmacological therapy options for COVID-19 and their effectiveness
- Share information on the impact that the COVID-19 pandemic has on clinical pharmacy practice
- List best practices presented by fellow clinical and hospital pharmacists from Belgium, Italy and the Netherlands
Register here> https://register.gotowebinar.com/register/6853799544053746701